A first-in-human trial of IDX21437, a new study drug being evaluated for hepatitis C virus infection.

Registry ID

EUCTR2013-004043-23

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Idenix Pharmaceuticals Inc.

Start date

2013-10-15

Last update

2026-08-16

Conditions

• Hepatitis C virus

Summary

• Safety and tolerability • Plasma and urine pharmacokinetics (PK) • The effect of food on the PK of IDX21437 • Antiviral activity

Locations

• , , Belgium

View on source registry